Colorado Residents: Filing a GLP-1 Drug Lawsuit in Your State

Thousands of Colorado residents rely on GLP-1 medications to manage Type 2 diabetes or support meaningful weight loss. These drugs have helped many people regain control of their health—but they’ve also left some patients facing unexpected and serious side effects.

Over the past few years, reports of severe gastrointestinal injuries have increased sharply. Patients have been hospitalized with gastroparesis (stomach paralysis), gallbladder disease requiring emergency surgery, and life-threatening bowel obstructions. Many of these individuals were never warned that these complications were possible.

If you’ve experienced any of these complications after using a GLP-1 drug, you may have legal options. At Boesen Law, our drug injury attorneys represent Colorado residents in pharmaceutical mass tort cases against some of the largest drug manufacturers in the world. Below, we’ll walk you through what you need to know before filing a GLP-1 drug lawsuit in Colorado, including what evidence matters most, how these cases are being handled nationwide, and what kind of compensation may be available to you.

What to Check Before You Move Forward

Before you move forward with a GLP-1 drug lawsuit in Colorado, it’s important to understand if you have the elements to build a valid case. In practice, we carefully evaluate each potential claim to ensure it has the evidence, timeline, and legal merit needed to succeed in what is often a long and complex litigation process.

That means we’re looking for more than just a diagnosis. We need to see a clear connection between your use of a GLP-1 medication and the injury you suffered. You’ll need documentation that shows when you started the drug, how your dosage changed, when your symptoms began, and what medical interventions followed.

If you’re wondering whether your situation qualifies, here’s what your lawyer will consider:

• Exposure history: Do your pharmacy records or EHR notes verify that you used a qualifying GLP-1 medication, that your dosage increased over time, and that your injury occurred within a plausible exposure window?
• Documented injury: Whether you underwent a gastric-emptying study for suspected gastroparesis, a cholecystectomy for gallbladder disease, or surgical treatment for bowel obstruction, gather objective evidence of your complications.
• Cured timeline and causation: Build a clear chronology showing that your symptoms followed GLP-1 use within a timeframe consistent with known drug-related risks. Address and rule out other potential causes, including rapid weight loss, preexisting biliary disease, or interactions with other medications.
• Jurisdictional fit: Colorado law sets the statute of limitations for personal injury filings at C.R.S. § 13-80-102 (typically 2 years from discovery).
• Forum awareness: While the bulk of GLP-1 cases are centralized in MDL 3094 (Eastern District of Pennsylvania), your claim may still start in Colorado, preserving venue advantages and evidence access before any transfer.

A successful GLP-1 injury lawsuit depends on thorough documentation and timing. Your attorney will help you gather the right evidence before settlement discussions or case transfers begin.

For answers to your questions, call:
(303) 999-9999

How Evidence Is Assembled

Building a strong GLP-1 case typically requires collecting the following evidence:

• Exposure documents: Pharmacy refill data, prescriber notes, and any upward dosing changes that indicate heightened risk.
• Clinical documents: ER records, imaging or tests (HIDA scan, CT for obstruction, gastric-emptying studies), operative and pathology reports.
• Causation and impact documents: Medical statements linking the injury to drug exposure, records of lost earnings or diminished capacity, and documentation of future care needs.

These are the elements most often scrutinized in MDL filings and settlement conferences. Without hospitalization records, diagnostic confirmation, and temporal linkage, even serious diagnoses may not survive the early filtering stage.

Common Defenses and How We Counter Them

Drug manufacturers and their legal teams don’t go into litigation unprepared. They deploy the same set of defenses in nearly every pharmaceutical injury case—defenses built to shift blame, delay accountability, and reduce settlement values. If you’ve been injured by a GLP-1 medication, you should expect these arguments:

• Preemption: Manufacturers argue that FDA-approved labeling shields them from liability. Our attorneys counter this by presenting evidence of side effects reported after the drug was approved, drawing on evidence from the FDA safety communications and expert testimony.
• Alternative causes: Defendants frequently blame rapid weight loss, dietary change, or preexisting gallbladder disease for the injury. We counter this through detailed intake questionnaires, timelines, and treating physician statements to demonstrate that symptoms appeared after drug exposure.
• Comparative fault in follow-up care: In some cases, manufacturers argue that patients ignored medical advice. A full medical chronology and compliance records help dismantle that claim.

What Compensation May Include

Compensation in GLP-1 drug injury cases is grounded in actual medical costs, wage losses, and the documented toll these injuries take on daily life. Colorado law allows plaintiffs to recover damages across several categories, and pharmaceutical defendants know this. That’s why they try to minimize severity early, challenge causation aggressively, and undervalue future care needs whenever possible.

Based on Colorado outcomes in pharmaceutical litigation and our own settlements, recoverable damages in a personal injury lawsuit related to GLP-1 drugs often include:

• Past and future medical care: Hospitalization, surgery, imaging, gastroenterology follow-up, and nutritional rehabilitation.
• Lost income and earning capacity: Compensation for time missed from work during recovery and any financial losses directly caused by the injury.
• Non-economic damages: Pain, reduced quality of life, and emotional distress.
• Punitive damages: Applied in cases of gross negligence, when evidence shows the manufacturer ignored known safety signals or delayed warning updates.

While no two settlements are identical, our attorneys ensure every claim includes life-care costs, wage losses, and documented pain and suffering to prevent undervaluation.

Preparing to File Your GLP-1 Drug Claim

If you suspect your injury is linked to Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, there are a few immediate steps to strengthen your potential case:

1. Request complete medical records from hospitals, imaging centers, and surgical facilities.
2. Obtain your pharmacy history with prescription dates and dosages.
3. Create a written symptom log noting onset, hospitalization dates, and current status.
4. Avoid signing insurer or manufacturer questionnaires until you’ve received legal help.

These steps protect your evidence, build the elements of a product liability claim, and ensure that once your attorney files, your claim meets both Colorado’s local standards and MDL 3094’s federal requirements.

How Our Attorneys Help Colorado Residents With GLP-1 Drug Lawsuits

Our attorneys help you navigate GLP-1 and other pharmaceutical injury cases by guiding you through every step of the process. We assist with gathering medical records, pharmacy data, and expert evaluations while documenting symptoms and future care needs. 

You can reach our mass torts team for a free consultation to discuss your eligibility. Once qualified, your lead attorney works directly with you to ensure your case reflects your specific circumstances.

Contact us today to get started.

FAQs About GLP-1 Drug Lawsuits for Colorado Residents

What injuries are most often reported in GLP-1 lawsuits?

The most common complications involve gastrointestinal paralysis (gastroparesis), bowel obstruction or ileus, and gallbladder disease that sometimes leads to gallbladder removal.

How do I know if my case qualifies under MDL 3094?

Qualifying claims require proof of both exposure and injury. This includes pharmacy documentation showing use of Ozempic, Wegovy, Mounjaro, or similar drugs; diagnostic imaging or surgical records; and a treating-physician statement linking onset to drug use.

Can I still file if I used a compounded or off-brand version?

Yes, but those cases are evaluated separately. The FDA has issued safety alerts about unapproved compounded GLP-1 products, and these claims often require additional testing or documentation to verify formulation and source.

Do I need to file in federal court, or can my attorney file in Colorado?

Colorado residents can begin in state court, but most qualified cases are later transferred into MDL 3094. Boesen Law files locally first to ensure deadlines and statutes of limitations are met before the transfer.

How long will the GLP-1 litigation take?

Pharmaceutical mass torts move slowly. Bellwether cases in MDL 3094 are still in early procedural stages, focusing on science and causation hearings. Our attorneys monitor those developments to position Colorado cases for early resolution or inclusion in future settlement rounds.

What compensation could I receive?

Recoverable damages depend on the medical and financial impact of your injury. Typical claims include surgery and hospitalization costs, lost income, future medical care, and pain and suffering.

When should I contact an attorney?

Immediately after confirming a diagnosis linked to GLP-1 use. Early representation ensures your attorney secures pharmacy and surgical records before they expire and files within Colorado’s statute of limitations. 

Call (303) 999-9999 or complete a Free Case Evaluation form